NAS revenues edge up, but loss widens in Q1

Strong gains in North American Scientific's radiation sources business segment were mostly offset by declines in its intensity-modulated radiation therapy/image-guided radiation therapy (IMRT/IGRT) business unit in its fiscal first quarter.

For the period (end-January 31), the Chatsworth, CA-based radiation therapy developer had revenues of $7.6 million, up slightly from the $7.5 million posted a year ago. The firm had a net loss of $3.2 million, compared with a net loss of $2.7 million in the fiscal first quarter of 2006.

In other developments, NAS said that it's on track to sell its first ClearPath breast brachytherapy products in the second quarter.

By AuntMinnie.com staff writers
March 15, 2007

Related Reading

NAS trims year-end losses, January 12, 2007

NAS receives 510(k) for ClearPath, November 14, 2006

North American Scientific unveils ClearPath, November 8, 2006

Cutrer to step down as NAS president/CEO, November 3, 2006

NAS gets nomosSTAT install, October 19, 2006

Copyright © 2007 AuntMinnie.com

Page 1 of 462
Next Page